| B | SE | t | 95% CI for B |
---|---|---|---|---|
Model 1 (BPD diagnosis → SDS) |  |  |  |  |
Total effect | 32.37 | 1.53 | 21.15*** | [29.36, 35.39] |
Direct effect | 9.56 | 2.42 | 3.94*** | [4.77, 14.35] |
Mediator: TAS-20 | 0.18 | 0.07 | 2.86** | [0.06, 0.31] |
Mediator: EDS | 0.16 | 0.06 | 2.75** | [0.05, 0.27] |
Mediator: STAI-Trait | 0.42 | 0.10 | 4.00*** | [0.21, 0.62] |
Mediator: CESD-R | 0.13 | 0.06 | 2.12* | [0.01, 0.25] |
Total indirect | 22.82 | 2.32 | 9.84*** | [18.16, 27.47] |
via TAS-20 | 3.77 | 1.29 | 2.92** | [1.30, 6.44] |
via EDS | 5.22 | 2.18 | 2.47* | [0.94, 9.58] |
via STAI-Trait | 9.19 | 2.58 | 3.57*** | [4.08, 14.13] |
via CESD-R | 4.63 | 2.39 | 1.94* | [0.08, 9.58] |
Model 2 (BPD Checklist → SDS) |  |  |  |  |
Total effect | 0.40 | 0.02 | 21.01*** | [0.36, 0.43] |
Direct effect | 0.04 | 0.04 | 1.10 | [–0.03, 0.11] |
Mediator: TAS-20 | 0.22 | 0.07 | 3.23*** | [0.09, 0.35] |
Mediator: EDS | 0.18 | 0.06 | 2.98** | [0.06, 0.30] |
Mediator: STAI-Trait | 0.44 | 0.11 | 3.92*** | [0.22, 0.66] |
Mediator: CESD-R | 0.21 | 0.06 | 3.30*** | [0.08, 0.34] |
Total indirect | 0.36 | 0.03 | 10.44*** | [0.29, 0.42] |
via TAS-20 | 0.06 | 0.02 | 3.41*** | [0.02, 0.09] |
via EDS | 0.08 | 0.03 | 2.60** | [0.02, 0.14] |
via STAI-Trait | 0.13 | 0.03 | 3.74*** | [0.06, 0.19] |
via CESD-R | 0.09 | 0.03 | 2.79** | [0.03, 0.16] |